Asia Pediatric Intensive Care Epidemiology and Outcomes Study
NCT ID: NCT06481644
Last Updated: 2025-08-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
10000 participants
OBSERVATIONAL
2024-08-01
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Profile of Pediatric Patients Admitted to AU ICU
NCT04324177
Nutritional Status of Critically Ill Children in Pediatric Intensive Care Units at Sohag University Hospitals
NCT07041658
Predictors of Acute Kidney Injury in Critically Ill Children Admitted to PICU.
NCT06328478
Vitamin A Status in Critically Ill Children With Sepsis and Its Association With Illness Severity
NCT03598127
Nutrition in Paediatric Critical Care
NCT06695078
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Though the main methodology is recruitment of all pediatric ICU admissions, a pre-determined random sampling protocol is allowed for sites with limited in resources for recruitment and data collection. This protocol may involve recruitment of all admissions for 1year (52 weeks), all admissions for 1 month per quarter over 1 year (16 weeks), all admissions for 1 week per month over 1 year (12 weeks), all admissions for 2 weeks per quarter over 1 year (8 weeks) or all admissions for 1 week for quarter over 1 year (4 weeks) - this will be declared at the start of the study by each participating site before recruitment begins. This strategy will allow us to include sites with and without sufficient resources to be represented in this study. As ethics approval will take time, each site may enter the study at differing time points and recruit for 1 year. Patients who have previously consented under the Singapore Pediatric Intensive Care Registry (SG-PedIC) under a similar single-center pilot study protocol which started from 2020 may be included. In the statistical analysis, random down sampling may be performed to avoid over-representation from high recruitment sites.
A planned subgroup study will be conducted for patients with and without pediatric chronic complex conditions (PCCC). PCCC represent a significant and growing subset of patients admitted to PICU. Although PCCCs make up only 10% to 17% of pediatric hospital admissions, they account for more than 50% of PICU admissions and use more than 75% of PICU resources. These conditions often involve multi-system involvement and prolonged hospitalizations, leading to substantial healthcare resource utilization and posing considerable challenges for clinical management. Understanding the characteristics, outcomes, and risk factors associated with these patients is crucial for improving clinical care and resource allocation. In this subgroup study, we will characterise patients with PCCCs, determine outcomes and identify risk factors for poor outcomes.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pediatric critical illness
All admissions to the pediatric ICU of participant hospitals without restriction to age, gender or race/ethnicity. Patients who have previously consented under the Singapore Pediatric Intensive Care Registry (SG-PedIC) under a similar single-center study protocol which started from 2020 will also be included.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
King Chulalongkorn Memorial Hospital
OTHER
Tengku Ampuan Rahimah Hospital
OTHER_GOV
King Abdullah Specialized Children's Hospital
UNKNOWN
Children's Hospital 2
UNKNOWN
University Malaysia Medical Centre
UNKNOWN
Saiful Anwar Hospital
OTHER
Murni Teguh Memorial Hospital
UNKNOWN
Siriraj Hospital
OTHER
Harapan Kita Women and Children Hospital
OTHER
Vicente Sotto Memorial Medical Center
UNKNOWN
Hong Kong Children's Hospital
OTHER
Ramathibodi Hospital
OTHER
Aga Khan University
OTHER
Aichi Children's Health and Medical Center, Japan
UNKNOWN
Hospital Sultanah Aminah Johor Bahru
OTHER_GOV
Children's hospital of Chonqing Medical University
UNKNOWN
Prof IGNG Ngoerah Hospital
UNKNOWN
Penang Hospital, Malaysia
OTHER_GOV
Vietnam National Children's Hospital
UNKNOWN
Hospital Pakar Kanak-kanak UKM
UNKNOWN
National University Hospital, Singapore
OTHER
Queen Elizabeth Hospital, Hong Kong
OTHER
KK Women's and Children's Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Judith Wong Ju-Ming
Dr
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Judith Ju Ming Wong
Role: PRINCIPAL_INVESTIGATOR
K K Women's and Children's Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
K K Women's and Children's Hospital
Singapore, , Singapore
King Chulalongkorn Memorial Hospital
Bangkok, , Thailand
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2015/2231
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.